Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
To Evaluate the Long-Term Safety of (R,R)-Formoterol in Subjects With COPD
This study has been completed.
Study NCT00064415 Information provided by Sepracor, Inc.
First Received: July 8, 2003 Last Updated: August 12, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Bronchitis
Emphysema
Additional conditions recognized in this trial
Bronchitis
Bronchitis, Chronic
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Pulmonary Emphysema
Respiration Disorders
More general conditions related to this trial
Bronchial Diseases
Pathologic Processes
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
arformoterol
Salmeterol
Additional drug interventions recognized in this trial
Formoterol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic beta-Agonists
Anti-Asthmatic Agents
Autonomic Agents
Bronchodilator Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Sepracor, Inc.
Back to top of Main Content
